BiotechTube
Home/Engimmune Therapeutics/Kenneth Crook, PhD
KC

Kenneth Crook, PhD

Head of Translational Medicine

Engimmune Therapeutics

Therapeutic Areas

OncologyAutoimmune Diseases

Engimmune Therapeutics Pipeline

DrugIndicationPhase
Lead Asset (undisclosed)Solid TumorsPreclinical

Leadership Team at Engimmune Therapeutics

LN
Lars Nieba, PhD
CEO
RV
Rodrigo Vazquez-Lombardi, PhD
Co-Founder & CSO
TS
Thomas Sandal
Head of CMC
SR
Sai Reddy, PhD
Co-Founder, Chairman of SAB
View full Engimmune Therapeutics profile